NO314435B1 - Lav-viskositets oftalmisk blanding - Google Patents

Lav-viskositets oftalmisk blanding Download PDF

Info

Publication number
NO314435B1
NO314435B1 NO19964071A NO964071A NO314435B1 NO 314435 B1 NO314435 B1 NO 314435B1 NO 19964071 A NO19964071 A NO 19964071A NO 964071 A NO964071 A NO 964071A NO 314435 B1 NO314435 B1 NO 314435B1
Authority
NO
Norway
Prior art keywords
weight
amount
viscosity
mixture
mixture according
Prior art date
Application number
NO19964071A
Other languages
English (en)
Norwegian (no)
Other versions
NO964071D0 (no
NO964071L (no
Inventor
Timo Reunamaeki
Kari Lehmussaari
Eija Vartiainen
Olli Oksala
Sakari Alaranta
Esko Pohjala
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of NO964071D0 publication Critical patent/NO964071D0/no
Publication of NO964071L publication Critical patent/NO964071L/no
Publication of NO314435B1 publication Critical patent/NO314435B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19964071A 1994-03-31 1996-09-27 Lav-viskositets oftalmisk blanding NO314435B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9401109A SE9401109D0 (sv) 1994-03-31 1994-03-31 Opthalmic composition II
PCT/FI1995/000167 WO1995026712A1 (en) 1994-03-31 1995-03-29 Ophthalmic composition containing an ion sensitive, hydrophilic polymer and an inorganic salt in a ratio which gives low viscosity

Publications (3)

Publication Number Publication Date
NO964071D0 NO964071D0 (no) 1996-09-27
NO964071L NO964071L (no) 1996-11-22
NO314435B1 true NO314435B1 (no) 2003-03-24

Family

ID=20393512

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19964071A NO314435B1 (no) 1994-03-31 1996-09-27 Lav-viskositets oftalmisk blanding

Country Status (25)

Country Link
US (1) US5795913A (cs)
EP (1) EP0755246B1 (cs)
JP (1) JPH10503471A (cs)
KR (1) KR970702025A (cs)
CN (1) CN1114399C (cs)
AT (1) ATE220538T1 (cs)
AU (1) AU694498B2 (cs)
BG (1) BG63144B1 (cs)
BR (1) BR9507439A (cs)
CA (1) CA2186591A1 (cs)
CZ (1) CZ286496A3 (cs)
DE (2) DE755246T1 (cs)
DK (1) DK0755246T3 (cs)
EE (1) EE03662B1 (cs)
ES (1) ES2179871T3 (cs)
HU (1) HU223070B1 (cs)
MX (1) MX9603919A (cs)
NO (1) NO314435B1 (cs)
PL (1) PL316585A1 (cs)
PT (1) PT755246E (cs)
RO (1) RO115410B1 (cs)
RU (1) RU2157194C2 (cs)
SE (1) SE9401109D0 (cs)
SK (1) SK281473B6 (cs)
WO (1) WO1995026712A1 (cs)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY116782A (en) * 1997-12-22 2004-03-31 Otsuka Pharma Co Ltd Water-soluble eye drop
WO2000064528A1 (en) 1999-04-28 2000-11-02 Situs Corporation Drug delivery system
AT407482B (de) * 1999-05-10 2001-03-26 Armin Dr Ettl Kalziumantagonistische augentropfen zur prophylaktischen behandlung der cataract
US6218428B1 (en) 2000-04-28 2001-04-17 Emil Chynn Ophthalmic composition
JP2005521690A (ja) * 2002-02-22 2005-07-21 ファルマシア・コーポレーション ゴム系を含む眼科用製剤
US7030149B2 (en) 2002-04-19 2006-04-18 Allergan, Inc. Combination of brimonidine timolol for topical ophthalmic use
US8877168B1 (en) 2002-07-31 2014-11-04 Senju Pharmaceuticals Co., Ltd. Aqueous liquid preparations and light-stabilized aqueous liquid preparations
KR101016595B1 (ko) 2002-07-31 2011-02-22 센주 세이야꾸 가부시키가이샤 수성액제 및 광안정화된 수성액제
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
DE102005035986B4 (de) * 2005-07-28 2009-10-15 Bausch & Lomb Incorporated Steriles tropfbares mehrphasiges emulgatorfreies ophthalmisches Präparat
US20080057022A1 (en) * 2006-08-30 2008-03-06 Erning Xia Ophthalmic Pharmaceutical Compositions and Uses Thereof
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure
IL212725A (en) 2011-05-05 2016-06-30 Resdevco Res And Dev Co Glycerol Preparation for Non-surgical Conjunctivochalysis
WO2017035408A1 (en) 2015-08-26 2017-03-02 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
CN121974842A (zh) 2016-05-10 2026-05-05 C4医药公司 用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体
JP2019517580A (ja) * 2016-06-01 2019-06-24 ハロルド・リチャード・ヘルストロムＨａｒｏｌｄ Ｒｉｃｈａｒｄ ＨＥＬＬＳＴＲＯＭ 副交感神経薬および抗交感神経薬でのドライアイ疾患の処置
MX2018016046A (es) 2016-06-27 2019-05-02 Achillion Pharmaceuticals Inc Quinazolina y compuestos indol para tratar trastornos medicos.
KR102472774B1 (ko) 2016-08-19 2022-11-30 오라시스 파마슈티칼스 엘티디. 안과용 약학 조성물 및 이와 관련된 용도
CA3053818A1 (en) 2017-03-01 2018-09-07 Achillion Pharmaceuticals, Inc. Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders
EP4717317A3 (en) 2017-06-20 2026-06-03 C4 Therapeutics, Inc. N/o-linked degrons and degronimers for protein degradation
CN111902141A (zh) 2018-03-26 2020-11-06 C4医药公司 用于ikaros降解的羟脑苷脂结合剂
JP6946575B2 (ja) 2018-04-24 2021-10-06 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ 眼の状態の治療のためのピロカルピン塩酸塩の使用
EP3841086B1 (en) 2018-08-20 2025-04-23 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement factor d medical disorders
JP7443375B2 (ja) 2018-09-06 2024-03-05 アキリオン ファーマシューティカルズ， インコーポレーテッド 医学的障害の治療のための大環状化合物
CN113365617B (zh) 2018-10-16 2025-12-23 乔治亚州立大学研究基金会股份有限公司 用于医学疾病治疗的一氧化碳前药
MX2021011507A (es) 2019-03-22 2021-12-15 Achillion Pharmaceuticals Inc Compuestos farmaceuticos para el tratamiento de trastornos mediados por complemento.
KR102947433B1 (ko) 2019-04-12 2026-04-06 씨4 테라퓨틱스, 인코포레이티드 이카로스 및 아이올로스의 트리시클릭 분해제
JP2023515073A (ja) 2020-02-20 2023-04-12 アキリオン ファーマシューティカルズ， インコーポレーテッド 補体因子ｄ媒介障害の処置用のヘテロアリール化合物
CN119823124A (zh) 2020-03-05 2025-04-15 C4医药公司 用于brd9的靶向降解的化合物
CA3193488A1 (en) 2020-09-23 2022-03-31 Jason Allan Wiles Pharmaceutical compounds for the treatment of complement mediated disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
GB2169508B (en) * 1985-01-11 1989-02-01 Smith & Nephew Ass Ophthalmic compositions and use
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
FR2678832B1 (fr) * 1991-07-10 1995-03-17 Europhta Sa Laboratoire Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation.
RU2007152C1 (ru) * 1992-10-01 1994-02-15 Курский Государственный Медицинский Институт Офтальмологическое средство и способ его получения

Also Published As

Publication number Publication date
EE9600157A (et) 1997-06-16
SE9401109D0 (sv) 1994-03-31
SK281473B6 (sk) 2001-04-09
US5795913A (en) 1998-08-18
CA2186591A1 (en) 1995-10-12
SK123896A3 (en) 1997-06-04
DE69527422T2 (de) 2003-03-20
CN1144476A (zh) 1997-03-05
PL316585A1 (en) 1997-01-20
BR9507439A (pt) 1997-09-16
HU223070B1 (hu) 2004-03-01
PT755246E (pt) 2002-11-29
JPH10503471A (ja) 1998-03-31
DK0755246T3 (da) 2002-11-04
EE03662B1 (et) 2002-04-15
WO1995026712A1 (en) 1995-10-12
DE69527422D1 (de) 2002-08-22
NO964071D0 (no) 1996-09-27
BG63144B1 (bg) 2001-05-31
NO964071L (no) 1996-11-22
KR970702025A (ko) 1997-05-13
RU2157194C2 (ru) 2000-10-10
EP0755246A1 (en) 1997-01-29
HU9602692D0 (en) 1996-11-28
ATE220538T1 (de) 2002-08-15
DE755246T1 (de) 1997-09-04
HUT75664A (en) 1997-05-28
ES2179871T3 (es) 2003-02-01
CZ286496A3 (en) 1997-03-12
AU2139095A (en) 1995-10-23
CN1114399C (zh) 2003-07-16
MX9603919A (es) 1997-04-30
EP0755246B1 (en) 2002-07-17
RO115410B1 (ro) 2000-02-28
BG100914A (en) 1997-07-31
AU694498B2 (en) 1998-07-23

Similar Documents

Publication Publication Date Title
NO314434B1 (no) Lav-viskositets oftalmisk blanding
EP0755246B1 (en) Ophthalmic composition containing an ion sensitive, hydrophilic polymer and an inorganic salt in a ratio which gives low viscosity
CA2153234C (en) Aqueous drug composition having property of reversible thermosetting gelation
US4425345A (en) Pharmaceutical composition containing triamterene
AU2010200297A1 (en) Ophthalmic compositions containing a synergistic combination of two polymers
CN101977630B (zh) 眼药组合物
WO2019091596A1 (en) Ophthalmic pharmaceutical composition containing a combination of brinzolamide and brimonidine and method of preparation thereof
EP4230193A1 (en) Ophthalmic pharmaceutical composition
GR1010024B (el) Φαρμακευτικο σκευασμα ελευθερο συντηρητικου για οφθαλμικη χορηγηση που περιλαμβανει βριμονιδινη
JP2000506182A (ja) 液―ゲル相転移を起こすタイプの点眼剤組成物
FI117921B (fi) Alennetun viskositeetin omaava oftalminen koostumus
KR20100032018A (ko) 항히스타민제를 포함하는 점안용 조성물
HK1013953B (en) Ophthalmic composition with decreased viscosity
HK1013955B (en) Ophthalmological preparation